57 related articles for article (PubMed ID: 8312053)
1. Increased efficacy of human natural interferon alpha (IFN-alpha n3) versus human recombinant IFN-alpha 2 for inhibition of HIV-1 replication in primary human monocytes.
Fan SX; Skillman DR; Liao MJ; Testa D; Meltzer MS
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1115-22. PubMed ID: 8312053
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma protects primary monocytes against infection with human immunodeficiency virus type 1.
Fan SX; Turpin JA; Aronovitz JR; Meltzer MS
J Leukoc Biol; 1994 Sep; 56(3):362-8. PubMed ID: 8083609
[TBL] [Abstract][Full Text] [Related]
4. Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes. Restricted antiviral activity of the HIV-induced IFN.
Gendelman HE; Baca LM; Kubrak CA; Genis P; Burrous S; Friedman RM; Jacobs D; Meltzer MS
J Immunol; 1992 Jan; 148(2):422-9. PubMed ID: 1729362
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
6. [Antiviral effect of recombinant interferon-alpha on hepatitis A virus replication in human liver cells].
Crance JM; Deloince R; Leveque F; Jouan A; Trépo C
C R Acad Sci III; 1994 Jan; 317(1):94-7. PubMed ID: 7987698
[TBL] [Abstract][Full Text] [Related]
7. Three-drug synergistic inhibition of HIV-1 replication in vitro by 3'-fluoro-3'-deoxythymidine, recombinant soluble CD4, and recombinant interferon-alpha.
Pan XZ; Qiu ZD; Baron PA; Gold JW; Polsky B; Chou TC; Armstrong D
AIDS Res Hum Retroviruses; 1992 May; 8(5):589-95. PubMed ID: 1515212
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.
Gendelman HE; Baca LM; Turpin J; Kalter DC; Hansen B; Orenstein JM; Dieffenbach CW; Friedman RM; Meltzer MS
J Immunol; 1990 Oct; 145(8):2669-76. PubMed ID: 1976701
[TBL] [Abstract][Full Text] [Related]
9. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
Gendelman HE; Baca L; Turpin JA; Kalter DC; Hansen BD; Orenstein JM; Friedman RM; Meltzer MS
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1045-9. PubMed ID: 2121192
[TBL] [Abstract][Full Text] [Related]
10. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of epidemic isolates of coxsackievirus type A 24 by recombinant and natural interferon alpha and interferon beta.
Langford MP; Kadi RM; Ganley JP; Yin-Murphy M
Intervirology; 1988; 29(6):320-7. PubMed ID: 2852655
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.
Capobianchi MR; Abbate I; Antonelli G; Turriziani O; Dolei A; Dianzani F
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):233-40. PubMed ID: 9491913
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b.
Dipaola M; Smith T; Ferencz-Biro K; Liao MJ; Testa D
J Interferon Res; 1994 Dec; 14(6):325-32. PubMed ID: 7897251
[TBL] [Abstract][Full Text] [Related]
14. [Persistence of type 1 human immunodeficiency virus (HIV-1) in MT-4 cells in presence of alpha-interferon].
Selimova LM; Iordanskiĭ SN; Kazennova EV; Bobkov AV
Vopr Virusol; 2001; 46(2):17-20. PubMed ID: 11392964
[TBL] [Abstract][Full Text] [Related]
15. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
Agy MB; Acker RL; Sherbert CH; Katze MG
Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
[TBL] [Abstract][Full Text] [Related]
16. Activity of superior interferon α against HIV-1 in severe combined immunodeficient mice reconstituted with human peripheral blood leukocytes.
Zhang W; Tong X; Nakasone T; Yue XT; Yamamoto N; Liu XY; Yang RG
Chin Med J (Engl); 2011 Feb; 124(3):396-400. PubMed ID: 21362340
[TBL] [Abstract][Full Text] [Related]
17. Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta.
Sperber SJ; Hayden FG
J Interferon Res; 1989 Jun; 9(3):285-93. PubMed ID: 2545792
[TBL] [Abstract][Full Text] [Related]
18. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.
Shirazi Y; Pitha PM
Virology; 1993 Mar; 193(1):303-12. PubMed ID: 8438572
[TBL] [Abstract][Full Text] [Related]
19. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication.
Francis ML; Meltzer MS
J Immunol; 1993 Aug; 151(4):2208-16. PubMed ID: 8345204
[TBL] [Abstract][Full Text] [Related]
20. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
